Koyfin Home > Directory > Health Care > Alexion Pharm Inc > EV / EBITDA (ntm)

Alexion Pharm Inc EV / EBITDA (ntm) Chart (ALXN)

Alexion Pharm Inc annual/quarterly EV / EBITDA (ntm) from 2010 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Alexion Pharm Inc EV / EBITDA (ntm) for the quarter ending October 10, 2020 was 7.37 a -0.61% decrease of -0.05 year over year
  • Alexion Pharm Inc EV / EBITDA (ntm) for the last 12 months ending October 10, 2020 was 7.37 a -0.61% decrease of -0.05 year over year
  • Alexion Pharm Inc Annual EV / EBITDA (ntm) for 2020 was 7.37 a 3.22% increase of 0.24 from 2019
  • Alexion Pharm Inc Annual EV / EBITDA (ntm) for 2020 was 7.13 a -3.31% decrease of -0.24 from 2019
  • Alexion Pharm Inc Annual EV / EBITDA (ntm) for 2020 was 7.37 a -0.63% decrease of -0.05 from 2019
Other Valuation Metrics:
  • Alexion Pharm Inc Market Cap for the quarter ending March 03, 2018 was $24,784m a -10.24% decrease of -2,538m year over year
  • Alexion Pharm Inc Price / Book for the quarter ending March 03, 2018 was 2.79 a -10.46% decrease of -0.29 year over year
  • Alexion Pharm Inc Enterprise Value for the quarter ending March 03, 2018 was $26,532m a -9.83% decrease of -2,609m year over year
View Chart On Koyfin

Quarterly ALXN EV / EBITDA (ntm) Data

10/20207.37
10/20207.13
10/20207.37
10/20207.41
10/20207.47
10/20207.35
10/20207.26
10/20207.19
10/20207.06
10/20207.20

Annual ALXN EV / EBITDA (ntm) Data

20207.37
20207.13
20207.37
20207.41
20207.47
20207.35
20207.26
20207.19
20207.06
20207.20